How Can Cost-Effectiveness Information Help Control Unsustainable Growth in U.S. Health Care Spending?

  1. Robert A. Murden, MD; and
  2. Eric E. Seiber, PhD
  1. From Ohio State University, Columbus, OH 43210.

    TO THE EDITOR:

    We read with interest the position paper on a national comparative effectiveness program (1) and the related editorials (2, 3). This is very timely because there is general agreement that the growth in health care spending in the United States is unsustainable. We contend that one of the most increasingly important contributors to rising costs is innovations with marginal benefits, and the only way to assess the benefit–financial risk ratio of these marginal benefits is precisely to tie cost-effectiveness …

    This 100-word excerpt has been provided in the absence of an abstract.

    Summaries for Patients

    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement